ALLMedicine™ Hypertension Center

Sep 23rd, 2021 - Polymeric nanomaterials with size ranging from 10 to 1000 nm are one of the most widely used types of nanoparticles with ideal properties in the drug delivery systems. Here, we decided to systematically review the antihypertensive effects of polym...

Sep 23rd, 2021 - The association between the Mediterranean diet (MED) or dietary approach to stop hypertension (DASH) and cardiovascular disease (CVD) risk factors is well-documented. Nevertheless, a consistent relationship with the Middle East population has yet ...

Sep 23rd, 2021 - Extracorporeal membrane oxygenation (ECMO) is increasingly utilized as a bridge to lung transplantation, but ECMO status is not explicitly accounted for in the Lung Allocation Score (LAS). We hypothesized that among waitlist patients on ECMO, pati...

Sep 23rd, 2021 - Hypertension is the largest contributor to the Global Burden of Disease. In Rwanda, as in most low-income and middle-income countries, an increasing prevalence of hypertension and its associated morbidity and mortality is causing major healthcare ...

Sep 23rd, 2021 - Non-alcoholic fatty liver disease (NAFLD) is an increasingly prevalent disease globally. Current estimates are that 24% of the adult population, thus, one billion individuals worldwide, are affected. Interestingly, the prevalence of fatty liver se...

Aug 24th, 2021 - ISHLT members have recognized the importance of a consensus statement on the evaluation and management of patients with chronic thromboembolic pulmonary hypertension. The creation of this document required multiple steps, including the engagement ...

Aug 19th, 2021 - Patients with connective tissue disease (CTD) present unique surgical, perioperative, operative, and postoperative challenges related to the often underlying severe pulmonary hypertension and right ventricular dysfunction. The International Societ...

Aug 1st, 2021 - Compensated advanced chronic liver disease (cACLD) describes the spectrum of advanced fibrosis/cirrhosis in asymptomatic patients at risk of developing clinically significant portal hypertension (CSPH, defined by a hepatic venous pressure gradient...

Aug 1st, 2021 - Primary biliary cholangitis (PBC) is a chronic inflammatory disease of the intra-hepatic bile ducts (1). It is characterised biologically by chronic cholestasis associated with the presence of specific autoantibodies, and histologically by lesions...

Jun 30th, 2021 - No robust evidence is provided by literature regarding the management of intracranial hypertension following severe traumatic brain injury (TBI). This is mostly due to the lack of prospective randomized controlled trials (RCTs), the presence of st...

Jul 21st, 2021 - NEW YORK (Reuters Health) - A new risk equation can accurately estimate the risk of chronic kidney disease (CKD) progressing to end-stage kidney disease (ESKD), the development team from France and Germany reports. The "Z6" risk equation is based ...

Jul 21st, 2021 - Takeaway A study found a non-linear inverse association between low birth weight (<2.88 kg) and the risk of hypertension. Furthermore, low birth weight and adult obesity (body mass index [BMI], ≥30 kg/m2) had a multiplicative interaction with resp...

Jul 15th, 2021 - NEW YORK (Reuters Health) - When chronic graft-versus-host disease (GVHD) follows an allogeneic stem-cell transplant, and it's either resistant to standard glucocorticoid therapy or dependent on glucocorticoids, ruxolitinib is better than other tr...

Jul 14th, 2021 - Takeaway The presence of hypertension and diabetes together was associated with a significantly increased risk of inpatient COVID-19 mortality. Furthermore, advanced age (>65 years), male sex, hypertension and cerebrovascular disease were independ...

Jul 12th, 2021 - (Reuters Health) - Ibrutinib is associated with rising blood pressure and increased risk of developing hypertension in patients with B cell malignancies, a new study suggests. Researchers examined data on 144 patients diagnosed with B cell maligna...